BioCentury
ARTICLE | Company News

Daiichi Sankyo, Egalet deal

January 12, 2015 8:00 AM UTC

Egalet purchased Sprix ketorolac tromethamine nasal spray from Daiichi Sankyo’s Luitpold Pharmaceuticals Inc. subsidiary for $7 million. The intranasal ketorolac analgesic is approved in the U.S. to ...